QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial

Repligen (RGEN) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free RGEN Stock Alerts
$164.17
-2.22 (-1.33%)
(As of 04:33 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 7Estimated
Actual EPS
(Feb. 21)
$0.33
Consensus EPS
(Feb. 21)
$0.33
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$0.29$0.75$0.41 
Q2 20244$0.31$0.83$0.45 
Q3 20244$0.38$0.85$0.50 
Q4 20244$0.44$0.91$0.56 
FY 202416$1.42$3.34$1.92 
Q1 20253$0.44$0.47$0.46 
Q2 20253$0.48$0.50$0.49 
Q3 20253$0.52$0.56$0.54 
Q4 20253$0.54$0.61$0.57 
FY 202512$1.98$2.14 $2.05

RGEN Earnings Date and Information

Repligen last posted its earnings data on February 21st, 2024. The biotechnology company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. The business had revenue of $155.74 million for the quarter, compared to analyst estimates of $155.38 million. Its revenue for the quarter was down 16.6% on a year-over-year basis. Repligen has generated $0.72 earnings per share over the last year ($0.72 diluted earnings per share) and currently has a price-to-earnings ratio of 228.9. Earnings for Repligen are expected to grow by 43.15% in the coming year, from $1.46 to $2.09 per share. Repligen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off prior year's report dates.

Repligen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Estimated)		------- 
2/21/2024Q4 2023$0.33$0.33-$1.12$155.38 million$155.74 million    
10/31/2023Q3 2023$0.14$0.23+$0.09$0.14$140.68 million$141.20 million    
8/2/2023Q2 2023$0.49$0.53+$0.04$0.71$165.93 million$159.20 million    
5/2/2023Q1 2023$0.59$0.64+$0.05$0.77$181.43 million$182.70 million    
2/22/2023Q4 2022$0.58$0.68+$0.10$0.51$184.41 million$186.80 million    
11/1/2022Q3 2022$0.68$0.77+$0.09$0.83$192.01 million$200.74 million
8/2/2022Q2 2022$0.72$0.91+$0.19$0.94$189.06 million$207.63 million    
4/27/2022Q1 2022$0.72$0.92+$0.20$1.03$185.48 million$206.40 million    
2/17/2022Q4 2021$0.65$0.81+$0.16$1.12$178.27 million$186.52 million    
10/28/2021Q3 2021$0.64$0.78+$0.14$0.98$163.97 million$178.22 million    
7/26/2021Q2 2021$0.52$0.79+$0.27$0.94$144.24 million$162.96 million    
5/4/2021Q1 2021$0.42$0.68+$0.26$0.84$117.88 million$142.80 million  

Repligen Earnings - Frequently Asked Questions

When is Repligen's earnings date?

Repligen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off last year's report dates. Learn more on RGEN's earnings history.

Did Repligen beat their earnings estimates last quarter?

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.33 earnings per share (EPS) to hit the analysts' consensus estimate of $0.33. Learn more on analysts' earnings estimate vs. RGEN's actual earnings.

How can I listen to Repligen's earnings conference call?

The conference call for Repligen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Repligen's conference call transcript?

The conference call transcript for Repligen's latest earnings report can be read online. Read Transcript

How much revenue does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $638.76 million.

How much profit does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded net income of $41.58 million. RGEN has generated $0.72 earnings per share over the last four quarters.

What is Repligen's price-to-earnings ratio?

Repligen (NASDAQ:RGEN) has a trailing price-to-earnings ratio of 228.91 and a forward price-to-earnings ratio of 112.88. The price/earnings-to-growth ratio is 5.62.

What is Repligen's EPS forecast for next year?

Repligen's earnings are expected to grow from $1.46 per share to $2.09 per share in the next year, which is a 43.15% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:RGEN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
The Greatest Bull Market in Crypto History…
Weiss Ratings